Home/Filings/4/0001209191-24-001065
4//SEC Filing

Kosacz Barbara 4

Accession 0001209191-24-001065

CIK 0001741830other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:26 PM ET

Size

5.2 KB

Accession

0001209191-24-001065

Insider Transaction Report

Form 4
Period: 2024-01-04
Kosacz Barbara
COO & General Counsel
Transactions
  • Sale

    Common Stock

    2024-01-04$1.18/sh10,676$12,636928,966 total
Footnotes (2)
  • [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
  • [F2]The weighted average sale price for the transaction reported was $1.1836, and the range of prices were between $1.12 to $1.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Issuer

Kronos Bio, Inc.

CIK 0001741830

Entity typeother

Related Parties

1
  • filerCIK 0001763316

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:26 PM ET
Size
5.2 KB